Skip to main content
We will be working on site updates on Wednesday, July 26. The platform should operate normally for most of the day, except for a 2-4 hour long disruption during maintenance. We apologize for any inconvenience.
3.15.150.100

Tags: PFR

All Categories (1-3 of 3)

  1. Scaling continuous API synthesis from milligram to kilogram: extending the enabling benefits of micro to the plant

    Contributor(s):: Berton, M, de, Souza, JMAbdiaj, I, McQuade, DT, Snead, DR

    The signature benefits of continuous flow are largely a result of a reactor's micro-sized features. However, as the technology gains industrial traction in the synthesis of active pharmaceutical ingredients (API), the reactors must be scaled to larger size to meet production demands. Often, the...

  2. Reactor design and selection for effective continuous manufacturing of pharmaceuticals

    Contributor(s):: Hu, Chuntian

    Pharmaceutical production remains one of the last industries that predominantly uses batch processes, which are inefficient and can cause drug shortages due to the long lead times or quality defects. Consequently, pharmaceutical companies are transitioning away from outdated batch lines, in large...

  3. Flow Chemistry, Continuous Processing, and Continuous Manufacturing: A Pharmaceutical Perspective

    Contributor(s):: May, SA

    Flow chemistry has become a vibrant area for Research Article over the past decade. This perspective is intended to capture insights on how these advances have and will continue to impact the development and commercialization of active pharmaceutical ingredients. A series of chemistry examples...